Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment-Experienced Patients”

366 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 366 results

Early research (Phase 1)Study completedNCT00569985
What this trial is testing

Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT00485225
What this trial is testing

Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain

Who this might be right for
Chronic, Non Malignant Pain
Durect 77
Testing effectiveness (Phase 2)Study completedNCT00004584
What this trial is testing

Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT00359021
What this trial is testing

An Open-label Trial With TMC125 in Patients Who Have Virologically Failed in a DUET Trial (TMC125-C206 or TMC125-C216).

Who this might be right for
HIV-1
Tibotec Pharmaceuticals, Ireland 503
Testing effectiveness (Phase 2)Study completedNCT00221650
What this trial is testing

Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients

Who this might be right for
HIV InfectionsHepatitis C, ChronicTreatment Failure
University Hospital, Bordeaux 17
Post-approval studies (Phase 4)Study completedNCT00980018
What this trial is testing

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 52
Large-scale testing (Phase 3)Active Not RecruitingNCT02362503
What this trial is testing

Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients

Who this might be right for
HIV Infections
ViiV Healthcare 371
Not applicableStudy completedNCT00262717
What this trial is testing

Can Resistance Enhance Selection of Treatment? (CREST)

Who this might be right for
HIV Infection
Kirby Institute 338
Post-approval studies (Phase 4)Study completedNCT00843713
What this trial is testing

Effect of Raltegravir on Endothelial Function in HIV-Infected Patients

Who this might be right for
HIV InfectionInflammationCardiovascular Disease+1 more
University of California, San Francisco 56
Large-scale testing (Phase 3)UnknownNCT00437684
What this trial is testing

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

Who this might be right for
HIV InfectionsHepatitis C
IRCCS San Raffaele 50
Testing effectiveness (Phase 2)Study completedNCT00784147
What this trial is testing

Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1

Who this might be right for
HIV
TaiMed Biologics Inc. 113
Post-approval studies (Phase 4)Study completedNCT03420300
What this trial is testing

EBR/GZR for HCV-1b Patients Receiving Hemodialysis

Who this might be right for
Hepatitis C
National Taiwan University Hospital 40
Not applicableStudy completedNCT00879411
What this trial is testing

Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients

Who this might be right for
Hypertension
Boehringer Ingelheim 670
Testing effectiveness (Phase 2)Study completedNCT01121731
What this trial is testing

A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Virus InfectionGenotype 1Treatment-Experienced Patients+1 more
Digna Biotech S.L. 70
Post-approval studies (Phase 4)UnknownNCT00843661
What this trial is testing

Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients

Who this might be right for
HIVHyperlipidemiaHIV Infections
Ospedale di Circolo - Fondazione Macchi 60
Post-approval studies (Phase 4)UnknownNCT01201239
What this trial is testing

Efficacy and Safety of Raltegravir (RAL) in Treatment-experienced HIV-1 Infected Adult Chinese Patients

Who this might be right for
HIV
Shanghai Public Health Clinical Center 50
Post-approval studies (Phase 4)Study completedNCT01675427
What this trial is testing

A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 4,766
Large-scale testing (Phase 3)Ended earlyNCT00447902
What this trial is testing

Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation

Who this might be right for
HIV Infections
Boehringer Ingelheim 11
Not applicableStudy completedNCT00925795
What this trial is testing

Effect of Extra Virgin Olive Oil on Atherosclerosis Biomarkers in HIV-infected Patients

Who this might be right for
HIVAtherosclerosisHIV Infections
University Hospital for Infectious Diseases, Croatia 39
Testing effectiveness (Phase 2)Study completedNCT00113282
What this trial is testing

Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 57
Load More Results